Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Oana M. Enache(Broad Institute), Uri Ben‐David(Tel Aviv University), Sasha Pantel(Broad Institute), Sangita Pal(Dana-Farber Cancer Institute), Anwesha Nag(Dana-Farber Cancer Institute), Rameen Beroukhim(Broad Institute), Francisca Vázquez(Dana-Farber Cancer Institute), Aaron R. Thorner(Center for Cancer Research), John G. Doench(Broad Institute), Mai Abdusamad(Broad Institute), Julian M. Hess(Broad Institute), Verónica Rendo(Uppsala University), Naomi Currimjee(Dana-Farber Cancer Institute), Todd R. Golub(Broad Institute), Desiree Davison(Broad Institute), Daniel D. Lam(Broad Institute)
Cited by 285
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k